APGE
Price
$57.35
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
SXTP
Price
$1.01
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
14 days until earnings call
Ad is loading...

APGE vs SXTP

Header iconAPGE vs SXTP Comparison
Open Charts APGE vs SXTPBanner chart's image
Apogee Therapeutics
Price$57.35
Change-$0.00 (-0.00%)
Volume$287.96K
CapitalizationN/A
60 Degrees Pharmaceuticals
Price$1.01
Change-$0.00 (-0.00%)
Volume$29.29K
CapitalizationN/A
APGE vs SXTP Comparison Chart
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SXTP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
APGE vs. SXTP commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a StrongSell and SXTP is a Buy.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (APGE: $57.35 vs. SXTP: $1.01)
Brand notoriety: APGE and SXTP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 70% vs. SXTP: 33%
Market capitalization -- APGE: $2.99B vs. SXTP: $1.81M
APGE [@Biotechnology] is valued at $2.99B. SXTP’s [@Biotechnology] market capitalization is $1.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileSXTP’s FA Score has 1 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • SXTP’s FA Score: 1 green, 4 red.
According to our system of comparison, APGE is a better buy in the long-term than SXTP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 4 TA indicator(s) are bullish while SXTP’s TA Score has 5 bullish TA indicator(s).

  • APGE’s TA Score: 4 bullish, 4 bearish.
  • SXTP’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SXTP is a better buy in the short-term than APGE.

Price Growth

APGE (@Biotechnology) experienced а -1.61% price change this week, while SXTP (@Biotechnology) price change was +11.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.86%. For the same industry, the average monthly price growth was +5.66%, and the average quarterly price growth was +6.44%.

Reported Earning Dates

APGE is expected to report earnings on Nov 12, 2024.

SXTP is expected to report earnings on Nov 27, 2024.

Industries' Descriptions

@Biotechnology (-1.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($2.99B) has a higher market cap than SXTP($1.81M). APGE YTD gains are higher at: 105.261 vs. SXTP (-91.748). SXTP has higher annual earnings (EBITDA): -1.49M vs. APGE (-134.74M). APGE has more cash in the bank: 676M vs. SXTP (1.58M). SXTP has less debt than APGE: SXTP (157K) vs APGE (4.08M). SXTP has higher revenues than APGE: SXTP (418K) vs APGE (0).
APGESXTPAPGE / SXTP
Capitalization2.99B1.81M164,920%
EBITDA-134.74M-1.49M9,069%
Gain YTD105.261-91.748-115%
P/E RatioN/AN/A-
Revenue0418K-
Total Cash676M1.58M42,866%
Total Debt4.08M157K2,601%
TECHNICAL ANALYSIS
Technical Analysis
APGESXTP
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
APGE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SXTP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DTGCX33.770.35
+1.05%
BNY Mellon Technology Growth C
GSELX77.01N/A
N/A
Goldman Sachs US Equity Insights Instl
FSIUX27.95-0.24
-0.85%
Invesco Dividend Income R5
CEUEX55.92-0.84
-1.48%
American Funds Europacific Growth 529E
RYOAX65.36-1.52
-2.27%
Rydex Biotechnology H

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
-5.14%
SYRE - APGE
39%
Loosely correlated
-9.15%
ACLX - APGE
39%
Loosely correlated
-5.68%
BHVN - APGE
38%
Loosely correlated
-3.95%
ALLO - APGE
36%
Loosely correlated
-8.09%
SRRK - APGE
34%
Loosely correlated
-5.33%
More

SXTP and

Correlation & Price change

A.I.dvisor tells us that SXTP and RVNC have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SXTP and RVNC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SXTP
1D Price
Change %
SXTP100%
+2.02%
RVNC - SXTP
23%
Poorly correlated
+19.71%
SPHRF - SXTP
21%
Poorly correlated
N/A
OABI - SXTP
20%
Poorly correlated
-2.39%
VRAX - SXTP
20%
Poorly correlated
-11.62%
APGE - SXTP
18%
Poorly correlated
-5.14%
More